This data suggests that DS-TB, at the transcriptional level, regulates TNF pathway molecules negatively due to anti-TB therapy; however, DR-TB patients cannot normalise the transcriptional level expression of TNF pathway molecules, keeping the high expression of these inflammatory molecules. This evidence concerns the gene TNF and tuberculosis.